Last reviewed · How we verify
gel xerostomia
At a glance
| Generic name | gel xerostomia |
|---|---|
| Also known as | lubricant and remineralizing agents |
| Sponsor | Universidad de Murcia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Integrated Oral Care Intervention for Xerostomia in Diabetes Patients (NA)
- Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention (PHASE2)
- Use of Two Dissolvable Therapeutics Under Removable Partial Dentures (NA)
- SDF Application in Oral Cancer Patients to Prevent Dental Caries (EARLY_PHASE1)
- Effect of Applying Oral Hygiene Care on Swallowing in Stroke Patients With Oropharyngeal Dysphagia (NA)
- Salivary Conductivity Screening for Dry Eye Disease and Sjögren's Syndrome
- Exploratory Study on Effect of Whitening Agent With Emulsion Gel in Xerostomic Population (NA)
- Fish Oil (Omega 3 ) in Sjogren's Syndrome (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- gel xerostomia CI brief — competitive landscape report
- gel xerostomia updates RSS · CI watch RSS
- Universidad de Murcia portfolio CI